Obesity in Diabetes
Metabolic·MeSH: Obesity
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| MET097 | PFIZER INC (PFE) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| met097 | PFIZER INC (PFE) |
Frequently asked questions
How many drugs are in development for Obesity in Diabetes?
BioSniper tracks 2 drugs in development for Obesity in Diabetes across 1 company.
How many clinical trials target Obesity in Diabetes?
There are 1 clinical trial targeting Obesity in Diabetes tracked by BioSniper.
What is the prevalence of Obesity in Diabetes?
The estimated prevalence of Obesity in Diabetes is approximately 42000.0 per 100,000 population.
Deep-dive into Obesity in Diabetes
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis